These observations of functional synergism between co-occurring ERBB3 mutations in vitro are also consistent with the findings that ERBB receptors are among the oncogenes that most frequently harbor multiple somatic mutations in clinical cancer samples [48]. Here, ERBB3 is linked to cancer.